speb/financial-data huggingface dataset:
MMED income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -10000000.00
MMED cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -7000000.00
MMED income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -7000000.00
MMED cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: 25000000.00
MMED cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -50000000.00
MMED income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 59000000.00
MMED income_statement (quarterly, 2025-01-31) — Normalized Income: -10000000.00
MMED cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 24000000.00
MMED cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 2000000.00
MMED income_statement (quarterly, 2025-01-31) — Operating Income: 22000000.00
MMED income_statement (quarterly, 2025-01-31) — Operating Revenue: 687000000.00
MMED cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 2000000.00
MMED income_statement (quarterly, 2025-01-31) — Other Operating Expenses: -7000000.00
MMED cash_flow (quarterly, 2025-01-31) — Pension And Employee Benefit Expense: 2000000.00
MMED income_statement (quarterly, 2025-01-31) — Pretax Income: 21000000.00
MMED cash_flow (quarterly, 2025-01-31) — Provisionand Write Offof Assets: 4000000.00
MMED cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -50000000.00
MMED income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 292000000.00
MMED income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 37000000.00
MMED income_statement (quarterly, 2025-01-31) — Research And Development: 112000000.00
MMED income_statement (quarterly, 2025-01-31) — Selling And Marketing Expense: 268000000.00
MMED income_statement (quarterly, 2025-01-31) — Selling General And Administration: 268000000.00
MMED income_statement (quarterly, 2025-01-31) — Special Income Charges: 0.00
MMED cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 10000000.00
MMED income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
MMED income_statement (quarterly, 2025-01-31) — Tax Provision: 28000000.00
MMED income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.21
MMED income_statement (quarterly, 2025-01-31) — Total Expenses: 665000000.00
MMED income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 21000000.00
MMED income_statement (quarterly, 2025-01-31) — Total Unusual Items: 0.00
MMED income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: 0.00
MMED income_statement (annual, 2025-04-30) — +Operating Expense: 1495000000.00
MMED income_statement (quarterly, 2025-04-30) — +Operating Expense: 440000000.00
MMED income_statement (annual, 2025-04-30) — +Total Revenue: 2715000000.00
MMED income_statement (quarterly, 2025-04-30) — +Total Revenue: 724000000.00
MMED balance_sheet (annual, 2025-04-30) — Accounts Payable: 205000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 205000000.00
MMED balance_sheet (annual, 2025-04-30) — Accounts Receivable: 570000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 570000000.00
MMED balance_sheet (annual, 2025-04-30) — Accumulated Depreciation: -663000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -663000000.00
MMED balance_sheet (annual, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -46000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -46000000.00
MMED cash_flow (annual, 2025-04-30) — Amortization Cash Flow: 29000000.00
MMED cash_flow (annual, 2025-04-30) — Amortization Of Intangibles: 29000000.00
MMED cash_flow (annual, 2025-04-30) — Asset Impairment Charge: 0.00
MMED income_statement (annual, 2025-04-30) — Basic Average Shares: 280813348.00
MMED income_statement (annual, 2025-04-30) — Basic EPS: -0.76
MMED cash_flow (annual, 2025-04-30) — Beginning Cash Position: 54000000.00
MMED cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 10000000.00
MMED balance_sheet (annual, 2025-04-30) — Buildings And Improvements: 233000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Buildings And Improvements: 233000000.00
MMED cash_flow (annual, 2025-04-30) — Capital Expenditure: -193000000.00
MMED cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -57000000.00
MMED balance_sheet (annual, 2025-04-30) — Capital Lease Obligations: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Capital Stock: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Capital Stock: 0.00
MMED balance_sheet (annual, 2025-04-30) — Cash And Cash Equivalents: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 11000000.00
MMED cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Financing Activities: 10000000.00
MMED cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -25000000.00
MMED cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Investing Activities: -193000000.00
MMED cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -57000000.00
MMED cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Operating Activities: 140000000.00
MMED cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 82000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Account Payable: 191000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Account Payable: 187000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Inventory: -19000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Inventory: 22000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Other Current Liabilities: 0.00
MMED cash_flow (annual, 2025-04-30) — Change In Other Working Capital: 16000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: 15000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Payable: 191000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Payable: 187000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Payables And Accrued Expense: 191000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 187000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Receivables: -66000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Receivables: -30000000.00
MMED cash_flow (annual, 2025-04-30) — Change In Working Capital: 122000000.00
MMED cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 194000000.00
MMED cash_flow (annual, 2025-04-30) — Changes In Account Receivables: -66000000.00
MMED cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -30000000.00
MMED cash_flow (annual, 2025-04-30) — Changes In Cash: -43000000.00
MMED cash_flow (quarterly, 2025-04-30) — Changes In Cash: 1000000.00
MMED balance_sheet (annual, 2025-04-30) — Common Stock: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Common Stock: 0.00
MMED balance_sheet (annual, 2025-04-30) — Common Stock Equity: 3331000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 3331000000.00
MMED cash_flow (annual, 2025-04-30) — Common Stock Issuance: 0.00
MMED balance_sheet (annual, 2025-04-30) — Construction In Progress: 286000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Construction In Progress: 286000000.00
MMED income_statement (annual, 2025-04-30) — Cost Of Revenue: 1187000000.00
MMED income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 321000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Accrued Expenses: 300000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 300000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Assets: 939000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Assets: 939000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Capital Lease Obligation: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Debt And Capital Lease Obligation: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Deferred Liabilities: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Deferred Revenue: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Current Liabilities: 710000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 710000000.00
MMED cash_flow (annual, 2025-04-30) — Deferred Income Tax: -2000000.00
MMED cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: -2000000.00
MMED cash_flow (annual, 2025-04-30) — Deferred Tax: -2000000.00
MMED cash_flow (quarterly, 2025-04-30) — Deferred Tax: -2000000.00
MMED cash_flow (annual, 2025-04-30) — Depreciation: 114000000.00
MMED cash_flow (annual, 2025-04-30) — Depreciation Amortization Depletion: 143000000.00
MMED cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 38000000.00
MMED cash_flow (annual, 2025-04-30) — Depreciation And Amortization: 143000000.00
MMED cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 38000000.00
MMED income_statement (annual, 2025-04-30) — Diluted Average Shares: 280813348.00
MMED income_statement (annual, 2025-04-30) — Diluted EPS: -0.76
MMED income_statement (annual, 2025-04-30) — Diluted NI Availto Com Stockholders: -213000000.00
MMED income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -209000000.00
MMED balance_sheet (annual, 2025-04-30) — Duefrom Related Parties Current: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Duefrom Related Parties Current: 0.00
MMED income_statement (annual, 2025-04-30) — EBIT: 33000000.00
MMED income_statement (quarterly, 2025-04-30) — EBIT: -38000000.00
MMED income_statement (annual, 2025-04-30) — EBITDA: 176000000.00
MMED income_statement (quarterly, 2025-04-30) — EBITDA: 0.00
MMED cash_flow (annual, 2025-04-30) — Effect Of Exchange Rate Changes: 0.00
MMED cash_flow (annual, 2025-04-30) — End Cash Position: 11000000.00
MMED cash_flow (quarterly, 2025-04-30) — End Cash Position: 11000000.00
MMED cash_flow (annual, 2025-04-30) — Financing Cash Flow: 10000000.00
MMED cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -25000000.00
MMED balance_sheet (annual, 2025-04-30) — Finished Goods: 185000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Finished Goods: 185000000.00
MMED cash_flow (annual, 2025-04-30) — Free Cash Flow: -53000000.00
MMED cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 26000000.00
MMED balance_sheet (annual, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 3000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 3000000.00
MMED balance_sheet (annual, 2025-04-30) — Goodwill: 2255000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Goodwill: 2255000000.00
MMED balance_sheet (annual, 2025-04-30) — Goodwill And Other Intangible Assets: 2386000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 2386000000.00
MMED balance_sheet (annual, 2025-04-30) — Gross Accounts Receivable: 616000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Gross Accounts Receivable: 616000000.00
MMED balance_sheet (annual, 2025-04-30) — Gross PPE: 1369000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Gross PPE: 1369000000.00
MMED income_statement (annual, 2025-04-30) — Gross Profit: 1528000000.00
MMED income_statement (quarterly, 2025-04-30) — Gross Profit: 402000000.00
MMED cash_flow (annual, 2025-04-30) — Income Tax Paid Supplemental Data: 0.00
MMED balance_sheet (annual, 2025-04-30) — Income Tax Payable: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 0.00
MMED balance_sheet (annual, 2025-04-30) — Inventory: 310000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Inventory: 310000000.00
MMED balance_sheet (annual, 2025-04-30) — Invested Capital: 3331000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Invested Capital: 3331000000.00
MMED cash_flow (annual, 2025-04-30) — Investing Cash Flow: -193000000.00
MMED cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -57000000.00
MMED cash_flow (annual, 2025-04-30) — Issuance Of Capital Stock: 0.00
MMED balance_sheet (annual, 2025-04-30) — Land And Improvements: 7000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Land And Improvements: 7000000.00
MMED balance_sheet (annual, 2025-04-30) — Machinery Furniture Equipment: 447000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 447000000.00
MMED balance_sheet (annual, 2025-04-30) — Minority Interest: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Minority Interest: 0.00
MMED income_statement (annual, 2025-04-30) — Minority Interests: -15000000.00
MMED income_statement (quarterly, 2025-04-30) — Minority Interests: 10000000.00
MMED cash_flow (annual, 2025-04-30) — Net Common Stock Issuance: 0.00
MMED income_statement (annual, 2025-04-30) — Net Income: -213000000.00
MMED income_statement (quarterly, 2025-04-30) — Net Income: -209000000.00
MMED income_statement (annual, 2025-04-30) — Net Income Common Stockholders: -213000000.00
MMED income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -209000000.00
MMED income_statement (annual, 2025-04-30) — Net Income Continuous Operations: -199000000.00
MMED income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -221000000.00
MMED income_statement (annual, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -213000000.00
MMED income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -209000000.00
MMED income_statement (annual, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -213000000.00
MMED income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -209000000.00
MMED cash_flow (annual, 2025-04-30) — Net Income From Continuing Operations: -198000000.00
MMED cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -168000000.00
MMED income_statement (annual, 2025-04-30) — Net Income Including Noncontrolling Interests: -198000000.00
MMED income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -220000000.00
MMED cash_flow (annual, 2025-04-30) — Net Investment Purchase And Sale: 0.00
MMED cash_flow (annual, 2025-04-30) — Net Other Financing Charges: 10000000.00
MMED cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -25000000.00
MMED balance_sheet (annual, 2025-04-30) — Net PPE: 706000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Net PPE: 706000000.00
MMED cash_flow (annual, 2025-04-30) — Net PPE Purchase And Sale: -193000000.00
MMED cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -57000000.00
MMED balance_sheet (annual, 2025-04-30) — Net Tangible Assets: 945000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 945000000.00
MMED balance_sheet (annual, 2025-04-30) — Non Current Accounts Receivable: 19000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Non Current Accounts Receivable: 19000000.00
MMED income_statement (annual, 2025-04-30) — Normalized EBITDA: 354000000.00
MMED income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 165000000.00
MMED income_statement (annual, 2025-04-30) — Normalized Income: -72380000.00
MMED income_statement (quarterly, 2025-04-30) — Normalized Income: -78650000.00
MMED cash_flow (annual, 2025-04-30) — Operating Cash Flow: 140000000.00
MMED cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 83000000.00
MMED cash_flow (annual, 2025-04-30) — Operating Gains Losses: 8000000.00
MMED cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: 2000000.00
MMED income_statement (annual, 2025-04-30) — Operating Income: 33000000.00
MMED income_statement (quarterly, 2025-04-30) — Operating Income: -38000000.00
MMED income_statement (annual, 2025-04-30) — Operating Revenue: 2715000000.00
MMED income_statement (quarterly, 2025-04-30) — Operating Revenue: 724000000.00
MMED balance_sheet (annual, 2025-04-30) — Ordinary Shares Number: 280813348.00
MMED balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 280813348.00
MMED balance_sheet (annual, 2025-04-30) — Other Current Assets: 48000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 48000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Current Liabilities: 1000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Current Liabilities: 1000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Equity Adjustments: 3000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: 3000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Equity Interest: 3328000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Equity Interest: 3328000000.00
MMED income_statement (annual, 2025-04-30) — Other Income Expense: -179000000.00
MMED income_statement (quarterly, 2025-04-30) — Other Income Expense: -165000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Intangible Assets: 131000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Intangible Assets: 131000000.00
MMED cash_flow (annual, 2025-04-30) — Other Non Cash Items: 5000000.00
MMED cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 2000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Non Current Assets: 150000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 150000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Non Current Liabilities: 160000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 160000000.00
MMED income_statement (annual, 2025-04-30) — Other Non Operating Income Expenses: -1000000.00
MMED income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: 0.00
MMED income_statement (annual, 2025-04-30) — Other Operating Expenses: -21000000.00
MMED income_statement (quarterly, 2025-04-30) — Other Operating Expenses: 4000000.00
MMED balance_sheet (annual, 2025-04-30) — Other Properties: 396000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Other Properties: 396000000.00
MMED income_statement (annual, 2025-04-30) — Other Special Charges: 165000000.00
MMED balance_sheet (annual, 2025-04-30) — Payables: 205000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Payables: 205000000.00
MMED balance_sheet (annual, 2025-04-30) — Payables And Accrued Expenses: 505000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 505000000.00
MMED cash_flow (annual, 2025-04-30) — Pension And Employee Benefit Expense: 8000000.00
MMED cash_flow (quarterly, 2025-04-30) — Pension And Employee Benefit Expense: 2000000.00
MMED balance_sheet (annual, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 182000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 182000000.00
MMED balance_sheet (annual, 2025-04-30) — Preferred Stock: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Preferred Stock: 0.00
MMED income_statement (annual, 2025-04-30) — Pretax Income: -147000000.00
MMED income_statement (quarterly, 2025-04-30) — Pretax Income: -204000000.00
MMED balance_sheet (annual, 2025-04-30) — Properties: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
MMED cash_flow (annual, 2025-04-30) — Provisionand Write Offof Assets: 21000000.00
MMED cash_flow (quarterly, 2025-04-30) — Provisionand Write Offof Assets: 8000000.00
MMED cash_flow (annual, 2025-04-30) — Purchase Of Investment: 0.00
MMED cash_flow (annual, 2025-04-30) — Purchase Of PPE: -193000000.00
MMED cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -57000000.00
MMED balance_sheet (annual, 2025-04-30) — Raw Materials: 87000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Raw Materials: 87000000.00
MMED balance_sheet (annual, 2025-04-30) — Receivables: 570000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Receivables: 570000000.00
MMED income_statement (annual, 2025-04-30) — Reconciled Cost Of Revenue: 1187000000.00
MMED income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 321000000.00
MMED income_statement (annual, 2025-04-30) — Reconciled Depreciation: 143000000.00
MMED income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 38000000.00
MMED income_statement (annual, 2025-04-30) — Research And Development: 436000000.00
MMED income_statement (quarterly, 2025-04-30) — Research And Development: 109000000.00
MMED income_statement (annual, 2025-04-30) — Restructuring And Mergern Acquisition: 13000000.00
MMED balance_sheet (annual, 2025-04-30) — Retained Earnings: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 0.00
MMED cash_flow (annual, 2025-04-30) — Sale Of Investment: 0.00
MMED income_statement (annual, 2025-04-30) — Selling And Marketing Expense: 1080000000.00
MMED income_statement (quarterly, 2025-04-30) — Selling And Marketing Expense: 327000000.00
MMED income_statement (annual, 2025-04-30) — Selling General And Administration: 1080000000.00
MMED income_statement (quarterly, 2025-04-30) — Selling General And Administration: 327000000.00
MMED balance_sheet (annual, 2025-04-30) — Share Issued: 280813348.00
MMED balance_sheet (quarterly, 2025-04-30) — Share Issued: 280813348.00
MMED income_statement (annual, 2025-04-30) — Special Income Charges: -178000000.00
MMED income_statement (quarterly, 2025-04-30) — Special Income Charges: -165000000.00
MMED cash_flow (annual, 2025-04-30) — Stock Based Compensation: 41000000.00
MMED cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 9000000.00
MMED balance_sheet (annual, 2025-04-30) — Stockholders Equity: 3331000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 3331000000.00
MMED balance_sheet (annual, 2025-04-30) — Tangible Book Value: 945000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 945000000.00
MMED income_statement (annual, 2025-04-30) — Tax Effect Of Unusual Items: -37380000.00
MMED income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: -34650000.00
MMED income_statement (annual, 2025-04-30) — Tax Provision: 52000000.00
MMED income_statement (quarterly, 2025-04-30) — Tax Provision: 17000000.00
MMED income_statement (annual, 2025-04-30) — Tax Rate For Calcs: 0.21
MMED income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.21
MMED balance_sheet (annual, 2025-04-30) — Total Assets: 4201000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Assets: 4201000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Capitalization: 3331000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 3331000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Debt: 11000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Debt: 11000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Equity Gross Minority Interest: 3331000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 3331000000.00
MMED income_statement (annual, 2025-04-30) — Total Expenses: 2682000000.00
MMED income_statement (quarterly, 2025-04-30) — Total Expenses: 761000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Liabilities Net Minority Interest: 870000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 870000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Non Current Assets: 3261000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 3261000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 160000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 160000000.00
MMED income_statement (annual, 2025-04-30) — Total Operating Income As Reported: -146000000.00
MMED income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: -204000000.00
MMED balance_sheet (annual, 2025-04-30) — Total Tax Payable: 0.00
MMED balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 0.00
MMED income_statement (annual, 2025-04-30) — Total Unusual Items: -178000000.00
MMED income_statement (quarterly, 2025-04-30) — Total Unusual Items: -165000000.00
MMED income_statement (annual, 2025-04-30) — Total Unusual Items Excluding Goodwill: -178000000.00
MMED income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -165000000.00
MMED balance_sheet (annual, 2025-04-30) — Work In Process: 38000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Work In Process: 38000000.00
MMED balance_sheet (annual, 2025-04-30) — Working Capital: 229000000.00
MMED balance_sheet (quarterly, 2025-04-30) — Working Capital: 229000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 129000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 166000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 3738000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Capital Stock: 3000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 350000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 350000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Common Stock: 3000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 3744000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 128000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Current Assets: 891000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 350000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Finished Goods: 199000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 8000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Goodwill: 2256000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 2375000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Gross Accounts Receivable: 166000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Inventory: 362000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Invested Capital: 3744000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Net PPE: 755000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 1369000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Non Current Accounts Receivable: 64000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 280813348.00
MMED balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 13000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: -1000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: 8000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 119000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 150000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 141000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Payables: 129000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 257000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 94000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Raw Materials: 112000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Receivables: 166000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -5000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Share Issued: 280813348.00
MMED balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 3744000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 1369000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Total Assets: 4235000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 3744000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 3744000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 491000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 3344000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 141000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Work In Process: 51000000.00
MMED balance_sheet (quarterly, 2025-10-31) — Working Capital: 541000000.00
MMED income_statement (quarterly, 2026-01-31) — +Operating Expense: 455000000.00
MMED income_statement (quarterly, 2026-01-31) — +Total Revenue: 790000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 303000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 653000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Allowance For Doubtful Accounts Receivable: -64000000.00
MMED income_statement (quarterly, 2026-01-31) — Basic Average Shares: 280813348.00
MMED income_statement (quarterly, 2026-01-31) — Basic EPS: -0.42
MMED cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 8000000.00
MMED cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -53000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 11000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 10000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 10000000.00
MMED cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -11000000.00
MMED cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -53000000.00
MMED cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 67000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Account Payable: 126000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Inventory: -43000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: 13000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Payable: 126000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 126000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Receivables: -74000000.00
MMED cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 22000000.00
MMED cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: -74000000.00
MMED cash_flow (quarterly, 2026-01-31) — Changes In Cash: 2000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 3463000000.00
MMED income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 428000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 186000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Assets: 1108000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 11000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 11000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 13000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 13000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 696000000.00
MMED cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 39000000.00
MMED cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 39000000.00
MMED income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 280813348.00
MMED income_statement (quarterly, 2026-01-31) — Diluted EPS: -0.42
MMED income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -119000000.00
MMED income_statement (quarterly, 2026-01-31) — EBIT: -93000000.00
MMED income_statement (quarterly, 2026-01-31) — EBITDA: -54000000.00
MMED cash_flow (quarterly, 2026-01-31) — End Cash Position: 10000000.00
MMED cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -11000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Finished Goods: 199000000.00
MMED cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 13000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 14000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Goodwill: 2256000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 2368000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Gross Accounts Receivable: 717000000.00
MMED income_statement (quarterly, 2026-01-31) — Gross Profit: 362000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Inventory: 407000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Invested Capital: 3463000000.00
MMED cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -53000000.00
MMED income_statement (quarterly, 2026-01-31) — Minority Interests: -8000000.00
MMED income_statement (quarterly, 2026-01-31) — Net Income: -119000000.00
MMED income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -119000000.00
MMED income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -111000000.00
MMED income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -119000000.00
MMED income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -119000000.00
MMED cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -111000000.00
MMED income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -111000000.00
MMED cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -11000000.00
MMED cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: 0.00
MMED balance_sheet (quarterly, 2026-01-31) — Net PPE: 701000000.00
MMED cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -53000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 1095000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Non Current Accounts Receivable: 19000000.00
MMED income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -47000000.00
MMED income_statement (quarterly, 2026-01-31) — Normalized Income: -114800000.00
MMED cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 66000000.00
MMED cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: 2000000.00
MMED income_statement (quarterly, 2026-01-31) — Operating Income: -93000000.00
MMED income_statement (quarterly, 2026-01-31) — Operating Revenue: 790000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 280813348.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 38000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: -1000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: 14000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Equity Interest: 3449000000.00
MMED income_statement (quarterly, 2026-01-31) — Other Income Expense: -7000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 112000000.00
MMED cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 4000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 146000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 184000000.00
MMED income_statement (quarterly, 2026-01-31) — Other Operating Expenses: 32000000.00
MMED income_statement (quarterly, 2026-01-31) — Other Special Charges: -6000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Payables: 303000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 489000000.00
MMED cash_flow (quarterly, 2026-01-31) — Pension And Employee Benefit Expense: 2000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 184000000.00
MMED income_statement (quarterly, 2026-01-31) — Pretax Income: -99000000.00
MMED cash_flow (quarterly, 2026-01-31) — Provisionand Write Offof Assets: 13000000.00
MMED cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -53000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Raw Materials: 164000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Receivables: 653000000.00
MMED income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 428000000.00
MMED income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 39000000.00
MMED income_statement (quarterly, 2026-01-31) — Research And Development: 114000000.00
MMED income_statement (quarterly, 2026-01-31) — Restructuring And Mergern Acquisition: 13000000.00
MMED income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 309000000.00
MMED income_statement (quarterly, 2026-01-31) — Selling General And Administration: 309000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Share Issued: 280813348.00
MMED income_statement (quarterly, 2026-01-31) — Special Income Charges: -7000000.00
MMED cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 12000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 3463000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 1095000000.00
MMED income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -2800000.00
MMED income_statement (quarterly, 2026-01-31) — Tax Provision: 12000000.00
MMED income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.40
MMED balance_sheet (quarterly, 2026-01-31) — Total Assets: 4343000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 3463000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Total Debt: 11000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 3463000000.00
MMED income_statement (quarterly, 2026-01-31) — Total Expenses: 883000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 880000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 3234000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 184000000.00
MMED income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: -100000000.00
MMED income_statement (quarterly, 2026-01-31) — Total Unusual Items: -7000000.00
MMED income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -7000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Work In Process: 44000000.00
MMED balance_sheet (quarterly, 2026-01-31) — Working Capital: 412000000.00
MMED income_statement (annual, 2026-04-30) — +Operating Expense: 1839000000.00
MMED income_statement (quarterly, 2026-04-30) — +Operating Expense: 567000000.00
MMED income_statement (annual, 2026-04-30) — +Total Revenue: 3102000000.00
MMED income_statement (quarterly, 2026-04-30) — +Total Revenue: 837000000.00
MMED balance_sheet (annual, 2026-04-30) — Accounts Payable: 163000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 163000000.00
MMED balance_sheet (annual, 2026-04-30) — Accounts Receivable: 200000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 200000000.00
MMED balance_sheet (annual, 2026-04-30) — Accumulated Depreciation: -781000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -781000000.00
MMED balance_sheet (annual, 2026-04-30) — Additional Paid In Capital: 3736000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 3736000000.00
MMED balance_sheet (annual, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -26000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -26000000.00
MMED cash_flow (annual, 2026-04-30) — Amortization Cash Flow: 26000000.00
MMED cash_flow (annual, 2026-04-30) — Amortization Of Intangibles: 26000000.00
MMED cash_flow (annual, 2026-04-30) — Asset Impairment Charge: 84000000.00
MMED cash_flow (quarterly, 2026-04-30) — Asset Impairment Charge: 0.00
MMED income_statement (annual, 2026-04-30) — Basic Average Shares: 256600000.00
MMED income_statement (annual, 2026-04-30) — Basic EPS: -1.30
MMED cash_flow (annual, 2026-04-30) — Beginning Cash Position: 11000000.00
MMED cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 10000000.00
MMED balance_sheet (annual, 2026-04-30) — Buildings And Improvements: 232000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Buildings And Improvements: 232000000.00
MMED cash_flow (annual, 2026-04-30) — Capital Expenditure: -223000000.00
MMED cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -56000000.00
MMED balance_sheet (annual, 2026-04-30) — Capital Lease Obligations: 8000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 8000000.00
MMED balance_sheet (annual, 2026-04-30) — Capital Stock: 3000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Capital Stock: 3000000.00
MMED balance_sheet (annual, 2026-04-30) — Cash And Cash Equivalents: 298000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 298000000.00
MMED balance_sheet (annual, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 298000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 298000000.00
MMED cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Financing Activities: 716000000.00
MMED cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 512000000.00
MMED cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Investing Activities: -233000000.00
MMED cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -56000000.00
MMED cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Operating Activities: -197000000.00
MMED cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -171000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Account Payable: 41000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 67000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Inventory: -29000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Inventory: 64000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Other Current Liabilities: 157000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Other Working Capital: 66000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: 31000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Payable: 178000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Payable: 204000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Payables And Accrued Expense: 178000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 204000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Receivables: -538000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Receivables: -444000000.00
MMED cash_flow (annual, 2026-04-30) — Change In Working Capital: -166000000.00
MMED cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 12000000.00
MMED cash_flow (annual, 2026-04-30) — Changes In Account Receivables: -83000000.00
MMED cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 11000000.00
MMED cash_flow (annual, 2026-04-30) — Changes In Cash: 286000000.00
MMED cash_flow (quarterly, 2026-04-30) — Changes In Cash: 287000000.00
MMED balance_sheet (annual, 2026-04-30) — Common Stock: 3000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Common Stock: 3000000.00
MMED balance_sheet (annual, 2026-04-30) — Common Stock Equity: 3611000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 3611000000.00
MMED cash_flow (annual, 2026-04-30) — Common Stock Issuance: 538000000.00
MMED balance_sheet (annual, 2026-04-30) — Construction In Progress: 241000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Construction In Progress: 241000000.00
MMED income_statement (annual, 2026-04-30) — Cost Of Revenue: 1422000000.00
MMED income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 357000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Accrued Expenses: 177000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 177000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Assets: 1348000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Assets: 1348000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Capital Lease Obligation: 8000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 8000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Debt: 137000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Debt: 137000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Debt And Capital Lease Obligation: 145000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 145000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Deferred Liabilities: 15000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 15000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Deferred Revenue: 15000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 15000000.00
MMED balance_sheet (annual, 2026-04-30) — Current Liabilities: 702000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 702000000.00
MMED cash_flow (annual, 2026-04-30) — Deferred Income Tax: -54000000.00
MMED cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: -55000000.00
MMED cash_flow (annual, 2026-04-30) — Deferred Tax: -54000000.00
MMED cash_flow (quarterly, 2026-04-30) — Deferred Tax: -55000000.00
MMED cash_flow (annual, 2026-04-30) — Depreciation: 130000000.00
MMED cash_flow (annual, 2026-04-30) — Depreciation Amortization Depletion: 156000000.00
MMED cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 39000000.00
MMED cash_flow (annual, 2026-04-30) — Depreciation And Amortization: 156000000.00
MMED cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 39000000.00
MMED income_statement (annual, 2026-04-30) — Diluted Average Shares: 256600000.00
MMED income_statement (annual, 2026-04-30) — Diluted EPS: -1.30
MMED income_statement (annual, 2026-04-30) — Diluted NI Availto Com Stockholders: -333000000.00
MMED income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -185000000.00
MMED balance_sheet (annual, 2026-04-30) — Duefrom Related Parties Current: 455000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Duefrom Related Parties Current: 455000000.00
MMED income_statement (annual, 2026-04-30) — EBIT: -159000000.00
MMED income_statement (quarterly, 2026-04-30) — EBIT: -87000000.00
MMED income_statement (annual, 2026-04-30) — EBITDA: -3000000.00
MMED income_statement (quarterly, 2026-04-30) — EBITDA: -48000000.00
MMED cash_flow (annual, 2026-04-30) — Effect Of Exchange Rate Changes: 1000000.00
MMED cash_flow (annual, 2026-04-30) — End Cash Position: 298000000.00
MMED cash_flow (quarterly, 2026-04-30) — End Cash Position: 298000000.00
MMED cash_flow (annual, 2026-04-30) — Financing Cash Flow: 716000000.00
MMED cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 512000000.00
MMED balance_sheet (annual, 2026-04-30) — Finished Goods: 179000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Finished Goods: 179000000.00
MMED cash_flow (annual, 2026-04-30) — Free Cash Flow: -420000000.00
MMED cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -226000000.00
MMED balance_sheet (annual, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -12000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -12000000.00
MMED balance_sheet (annual, 2026-04-30) — Goodwill: 2256000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Goodwill: 2256000000.00
MMED balance_sheet (annual, 2026-04-30) — Goodwill And Other Intangible Assets: 2362000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 2362000000.00
MMED balance_sheet (annual, 2026-04-30) — Gross Accounts Receivable: 226000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 226000000.00
MMED balance_sheet (annual, 2026-04-30) — Gross PPE: 1492000000.00
MMED balance_sheet (quarterly, 2026-04-30) — Gross PPE: 1492000000.00